Episode Details

Niklas Anzinger joins Eric to discuss how biotech innovation and alternative governance models are opening new possibilities for healthcare and entrepreneurship. He shares insights from his work with experimental regulatory environments and efforts to expand patient access to cutting-edge treatments. The conversation highlights New Hampshire’s growing role as a potential biotech hub and a testing ground for policy innovation. More broadly, it explores how emerging technologies are challenging traditional systems and reshaping the future of medicine.